SLN
MaterialsSilence Therapeutics Plc
Live · NASDAQ · May 9, Close
What's Moving SLN Today?
No stock-specific AI insight has been generated for SLN yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
SLN News
21 articles- European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday TradingYahoo Finance·May 7, 2026
- European Equities Traded in the US as American Depositary Receipts Lower in Wednesday TradingYahoo Finance·Apr 29, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Friday TradingYahoo Finance·Apr 24, 2026
- European Equities Traded in US as ADRs Ease in Thursday TradingYahoo Finance·Apr 23, 2026
- Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsightGlobeNewswire Inc.·Apr 22, 2026
- European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday TradingYahoo Finance·Apr 22, 2026
- European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday TradingYahoo Finance·Apr 21, 2026
- Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?Yahoo Finance·Apr 16, 2026
- European Equities Traded in the US as ADRs Rise in Tuesday TradingYahoo Finance·Apr 14, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday TradingYahoo Finance·Apr 13, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Thursday TradingYahoo Finance·Apr 9, 2026
- European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday TradingYahoo Finance·Apr 7, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Monday TradingYahoo Finance·Apr 6, 2026
- We Think Silence Therapeutics (NASDAQ:SLN) Needs To Drive Business Growth CarefullyYahoo Finance·Apr 1, 2026
- European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday TradingYahoo Finance·Mar 27, 2026
- European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday TradingYahoo Finance·Mar 25, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Tuesday TradingYahoo Finance·Mar 24, 2026
- European Equities Traded in the US as American Depositary Receipts Climb in Monday TradingYahoo Finance·Mar 23, 2026
- European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday TradingYahoo Finance·Mar 19, 2026
- European Equities Traded in US as ADRs Fall in Wednesday TradingYahoo Finance·Mar 18, 2026
- European Equities Traded in the US as American Depositary Receipts Higher MondayYahoo Finance·Mar 16, 2026
All 21 articles loaded
Price Data
Fundamentals
Trading
About Silence Therapeutics Plc
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.